Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 08, 2019
MilliporeSigma has introduced its ADC Express services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.
read more
Tuesday, November 19, 2019
Accord Healthcare Limited and ADIENNE Pharma & Biotech have entered into an exclusive licensing and distribution agreement for the commercialization of TEPADINA.
read more
Clearside Biomedical announced an update to the XIPERE NDA resubmission timeline and to its commercialization and development partnership with Bausch Health and Bausch + Lomb, its global eye health business.
read more
Monday, December 10, 2018
SGS is investing €3.5 million to undertake a two-phase expansion project at its laboratory in Poitiers, France, to implement a 50% increase in bioanalytical capabilities at the site by 2020.
read more
A new study published in Open Access journal PLOS Biology by the Global Biological Standards Institute (GBSI) and two leading economists estimates that, in the U.S. alone, approximately $28 billion per year is spent on preclinical research that is ...
read more
Wednesday, December 19, 2018
Sandoz has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.
read more
Asahi Kasei has established Asahi Kasei Life Science, a new organizational structure dedicated to its bioprocess businesses. This move reflects the company’s commitment to addressing the evolving needs of the pharmaceutical industry by enhancing ...
read more
Thursday, October 03, 2019
Catalent announced Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.
read more
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
read more
Wednesday, August 24, 2016
Pfizer has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily outside the United States.
read more
PANTHERx has been selected by Otsuka distribute JYNARQUE, the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
Wednesday, September 11, 2024
Syntekabio an artificial intelligence (AI)-driven drug development company, announced the appointment of Joonhyuk Choi, former CEO of Target Health, as Head of US Operations.
Joonhyuk brings over 25 years of extensive experience in the ...
read more
Wednesday, December 03, 2025
Avance Biosciences announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company's capabilities in potency and functional cell-based assays under GMP ...
read more
Thursday, December 04, 2025
Cellipont Bioservices announced the completion of its ballroom-style cleanroom, featuring a state-of-the-art 50-liter single-use bioreactor. This facility expansion marks a major milestone in Cellipont's continued investment to meet the growing ...
read more
PCI Pharma Services (PCI) announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational.
read more